IFCT is an independent, non-profit academic research intergroup specializing in thoracic oncology.
Its objective is to improve survival and quality of life for thoracic cancer patients. Established in 1999, the IFCT consolidates medical and scientific expertise in thoracic oncology, giving it the unique capacity to recruit patients for all phases of cancer treatment evaluation.
IFCT has its own operational infrastructure and is equipped to design, promote, and carry out clinical studies in France and internationally, and to communicate the findings thus obtained. IFCT is a major player in clinical oncology research, with thousands of patients enrolled in investigations since its establishment, and findings published in the most highly recognized medical journals (Lancet, JCO, etc.). IFCT’s activity regularly results in the introduction of new drugs or strategies that improve the efficacy, safety, and/or economic impact of anti-cancer therapies. This in turn leads to better patient management. IFCT also got involved since decade to develop the translational research) by associating systematically one or several studies with every clinical trial.
IFCT projects are coordinated by a Clinical Research Unit accredited by the National Cancer Institute (INCa) and the National League Against Cancer.